Normal view MARC view ISBD view

Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma.

Johnston, Patrick B

Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma. [electronic resource] - Experimental hematology & oncology 2018 - 12 p. digital

Publication Type: Journal Article

ISSN: 2162-3619

Standard No.: 10.1186/s40164-018-0103-z doi

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)